Three-layer structure
Amnion, intermediate layer, and chorion remain combined.
An amnion/chorion allograft that preserves the intermediate layer. Explore the architecture, biological components, and clinical context behind this protective covering.

*Product specifications; current labeling and lot documentation take precedence.
Amnion, intermediate layer, and chorion remain combined.
Naturally occurring extracellular matrix components and regulatory proteins.
Intended for homologous use as a protective covering.
No frozen storage requirement. Follow current product labeling.
Aseptic processing with e-beam terminal sterilization.
Confirm the expiration date printed on each individual package.
AmnioWrap2 preserves the combined amnion, intermediate layer, and chorion, including the extracellular matrix and naturally occurring regulatory proteins found in placental tissue.
The BioRetain® process is designed to preserve native tissue components. Explore each layer below.
CONCEPTUAL TISSUE ARCHITECTUREPlacental membranes contain an extracellular matrix: a structural network that includes collagen and other tissue components. AmnioWrap2 retains the intermediate layer between the amnion and chorion.
Understand tissue allografts
Terminally sterilized using e-beam irradiation.
Refer to the current label and instructions for use for storage conditions.
Use the expiration date on the individual product label.
Product specifications reflect the existing R812 product information. Always follow the current manufacturer instructions for use.
Compare rectangular dimensions with the listed graft range.
Enter both measurements to find the smallest listed sheet that covers the dimensions, allowing rotation.
The library includes a retrospective comparison of retention-processed amnion/chorion membranes and standard of care in diabetic foot ulcers, alongside wound-care case studies.
Review the full methods, study limitations, and patient population when interpreting results.
Explore AmnioWrap2 resourcesHomologous use as a protective covering. Refer to the current product instructions for use for complete indications and handling.
Amnion, the intermediate layer, and chorion. R812’s product information describes retained extracellular matrix components, cytokines, and endogenous growth factors.
Existing customers can sign in to the R812 customer portal. Clinics that need access can use the account request flow. Distribution enquiries should be directed to the R812 team.
Medicare and some commercial plans may cover qualifying tissue-based wound products when their policy criteria are met. Coverage is specific to the product, indication, patient, and care setting.
Explore coverage considerationsCheck the patient’s plan, the applicable Medicare contractor, and the exact product.
Review wound history, prior standard care, measurements, and the treatment plan.
Confirm authorization, coding, benefit limits, and patient responsibility with the payer.
Coverage is not guaranteed for AmnioWrap2 or any individual claim. This tissue-allograft information does not apply to PBME Topical. Sources: CMS coverage policy · Commercial payer example.
Explore products for your practice, request clinic access, or speak with our team about your needs.